172 related articles for article (PubMed ID: 20039567)
1. Learn to assess for and manage trastuzumab-induced cardiotoxicity.
Becze E
ONS Connect; 2009 Dec; 24(12):12-3. PubMed ID: 20039567
[No Abstract] [Full Text] [Related]
2. Trastuzumab.
Nurs Times; 2006 Mar 7-13; 102(10):33. PubMed ID: 16548266
[No Abstract] [Full Text] [Related]
3. Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter.
Morris PG; Hudis CA
Breast Cancer Res Treat; 2011 Jun; 127(2):585-6. PubMed ID: 18791822
[No Abstract] [Full Text] [Related]
4. Trastuzumab in breast cancer.
Gilbert SG
N Engl J Med; 2006 Feb; 354(6):640-4; author reply 640-4. PubMed ID: 16467555
[No Abstract] [Full Text] [Related]
5. Heart of darkness: the downside of trastuzumab.
Hayes DF; Picard MH
J Clin Oncol; 2006 Sep; 24(25):4056-8. PubMed ID: 16908930
[No Abstract] [Full Text] [Related]
6. Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?
Ewer MS; Tan-Chiu E
J Clin Oncol; 2007 Dec; 25(34):5532-3; author reply 5533-4. PubMed ID: 18048835
[No Abstract] [Full Text] [Related]
7. Impact on cardiac toxicity with trastuzumab and radiotherapy: the question is still ongoing.
Magné N; Védrine L; Chargari C
J Clin Oncol; 2009 Dec; 27(34):e239; author reply e240-1. PubMed ID: 19884526
[No Abstract] [Full Text] [Related]
8. Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice.
Goel S; Beith JM
J Clin Oncol; 2011 Mar; 29(7):e175-6. PubMed ID: 21189375
[No Abstract] [Full Text] [Related]
9. Trastuzumab before breast surgery? Large trial says yes but does not quell debate.
Rowan K
J Natl Cancer Inst; 2009 Apr; 101(7):448-9. PubMed ID: 19318626
[No Abstract] [Full Text] [Related]
10. Trastuzumab-induced cardiac dysfunction.
Panjrath GS; Jain D
Nucl Med Commun; 2007 Feb; 28(2):69-73. PubMed ID: 17198344
[No Abstract] [Full Text] [Related]
11. Trastuzumab beyond progression: is the risk of cardiac toxicity really not increased?
Morabito A; Piccirillo MC; De Maio E; Di Maio M; Perrone F
J Clin Oncol; 2009 Sep; 27(27):e123; author reply e124-5. PubMed ID: 19687322
[No Abstract] [Full Text] [Related]
12. [Trastuzumab (Herceptin)].
Tokuda Y; Suzuki Y; Saitou Y; Ohta M; Tajima T
Gan To Kagaku Ryoho; 2002 Apr; 29(4):645-52. PubMed ID: 11977556
[TBL] [Abstract][Full Text] [Related]
13. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.
Telli ML; Hunt SA; Carlson RW; Guardino AE
J Clin Oncol; 2007 Aug; 25(23):3525-33. PubMed ID: 17687157
[TBL] [Abstract][Full Text] [Related]
14. Cardiotoxicity associated with trastuzumab (Herceptin) therapy in the treatment of metastatic breast cancer.
Suter TM; Cook-Bruns N; Barton C
Breast; 2004 Jun; 13(3):173-83. PubMed ID: 15177418
[TBL] [Abstract][Full Text] [Related]
15. Controversies in the use of adjuvant trastuzumab (Herceptin).
Chowdhury S; Pickering L; Ellis P
J Br Menopause Soc; 2006 Dec; 12(4):172-4. PubMed ID: 17178019
[TBL] [Abstract][Full Text] [Related]
16. Cardiac issues related to trastuzumab.
Perez EA
Breast; 2004 Jun; 13(3):171-2. PubMed ID: 15177417
[No Abstract] [Full Text] [Related]
17. Trastuzumab trials steal show at ASCO meeting.
Tuma RS
J Natl Cancer Inst; 2005 Jun; 97(12):870-1. PubMed ID: 15956644
[No Abstract] [Full Text] [Related]
18. Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer.
Fiúza M
Adv Ther; 2009 Jul; 26 Suppl 1():S9-17. PubMed ID: 19669637
[TBL] [Abstract][Full Text] [Related]
19. Trastuzumab-related cardiotoxicity following anthracycline-based adjuvant chemotherapy: how worried should we be?
Morris PG; Hudis CA
J Clin Oncol; 2010 Jul; 28(21):3407-10. PubMed ID: 20530269
[No Abstract] [Full Text] [Related]
20. Trastuzumab-associated cardiotoxicity.
Keefe DL
Cancer; 2002 Oct; 95(7):1592-600. PubMed ID: 12237930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]